Solventum Corporation
Solventum Corporation (SOLV) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Solventum Corporation (SOLV), featuring income statements, balance sheets, and cash flow data.
Solventum Corporation (SOLV) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Solventum Corporation SOLV financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.07B | $2.08B | $2.08B | $2.08B |
| Cost of Revenue | $956.00M | $956.00M | $917.00M | $944.00M |
| Gross Profit | $1.11B | $1.12B | $1.17B | $1.14B |
| Gross Profit Ratio | $0.54 | $0.54 | $0.56 | $0.55 |
| R&D Expenses | $193.00M | $199.00M | $189.00M | $192.00M |
| SG&A Expenses | $769.00M | $784.00M | $701.00M | $701.00M |
| Operating Expenses | $962.00M | $983.00M | $890.00M | $893.00M |
| Total Costs & Expenses | $1.92B | $1.94B | $1.81B | $1.84B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $104.00M | $107.00M | $107.00M | $114.00M |
| Depreciation & Amortization | $129.00M | $150.00M | $133.00M | $133.00M |
| EBITDA | $271.00M | $270.00M | $407.00M | $343.00M |
| EBITDA Ratio | $0.13 | $0.13 | $0.20 | $0.16 |
| Operating Income | $152.00M | $136.00M | $275.00M | $244.00M |
| Operating Income Ratio | $0.07 | $0.07 | $0.13 | $0.12 |
| Other Income/Expenses (Net) | -$114.00M | -$123.00M | -$108.00M | -$148.00M |
| Income Before Tax | $38.00M | $13.00M | $167.00M | $96.00M |
| Income Before Tax Ratio | $0.02 | $0.006 | $0.08 | $0.05 |
| Income Tax Expense | -$99.00M | -$17.00M | $45.00M | $7.00M |
| Net Income | $137.00M | $31.00M | $122.00M | $89.00M |
| Net Income Ratio | $0.07 | $0.01 | $0.06 | $0.04 |
| EPS | $0.79 | $0.17 | $0.70 | $0.51 |
| Diluted EPS | $0.78 | $0.17 | $0.70 | $0.51 |
| Weighted Avg Shares Outstanding | $173.70M | $173.40M | $173.40M | $173.20M |
| Weighted Avg Shares Outstanding (Diluted) | $174.80M | $174.50M | $173.90M | $173.50M |
Financial performance has remained strong, with revenue growing from $2.08B in Q2 2024 to $2.07B in Q1 2025. Gross profit continued to perform well, with margins at 54% in the latest quarter. Operating income reached $152.00M in Q1 2025, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $271.00M. Net income rose to $137.00M, keeping EPS at $0.79. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan